ID

39376

Description

A Study of LY2605541 Versus Insulin Glargine on Blood Sugar; ODM derived from: https://clinicaltrials.gov/show/NCT01654380

Lien

https://clinicaltrials.gov/show/NCT01654380

Mots-clés

Versions (1)
  1. 04/01/2020 04/01/2020 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

4 janvier 2020

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Healthy Volunteers NCT01654380

Anglais

Eligibility Healthy Volunteers NCT01654380

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
all participants
Description

Study Subject All

Type de données

boolean

Alias
UMLS CUI [1,1]
C0681850
UMLS CUI [1,2]
C0444868
are healthy males or participants with t1dm
Description

Gender Healthy | Diabetes Mellitus, Insulin-Dependent

Type de données

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C3898900
UMLS CUI [2]
C0011854
have a screening body mass index (bmi) of 20.0-29.9 kilograms per square meter (kg/m^2)
Description

Body mass index

Type de données

boolean

Alias
UMLS CUI [1]
C1305855
healthy participants only
Description

Healthy Volunteers

Type de données

boolean

Alias
UMLS CUI [1]
C1708335
are overtly healthy, as determined by medical history and physical examination
Description

Healthy Volunteers Medical History | Healthy Volunteers Physical Examination

Type de données

boolean

Alias
UMLS CUI [1,1]
C1708335
UMLS CUI [1,2]
C0262926
UMLS CUI [2,1]
C1708335
UMLS CUI [2,2]
C0031809
have a fasting blood glucose <108 milligrams/deciliter (mg/dl) (6.0 millimoles/liter [mmol/l]) at screening
Description

Fasting blood glucose measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0428568
participants with t1dm only
Description

Study Subject Insulin-Dependent Diabetes Mellitus

Type de données

boolean

Alias
UMLS CUI [1,1]
C0681850
UMLS CUI [1,2]
C0011854
have a diagnosis of t1dm for at least 1 year based on medical history
Description

Insulin-Dependent Diabetes Mellitus Disease length

Type de données

boolean

Alias
UMLS CUI [1,1]
C0011854
UMLS CUI [1,2]
C0872146
have a screening c-peptide <0.5 nanogram/milliliter (ng/ml)
Description

C-peptide measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0202100
have a hemoglobin a1c (hba1c) of 6.0 to 9.0% at screening
Description

Hemoglobin A1c measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0474680
have had no episodes of severe hypoglycemia in the past 6 months (severe hypoglycemia is defined as having neurological symptoms consistent with neuroglycopenia and having required assistance in treatment by a second party)
Description

Absence Episode of Hypoglycemia Severe | Absence Neurologic Symptoms Consistent with Neuroglycopenia

Type de données

boolean

Alias
UMLS CUI [1,1]
C0332197
UMLS CUI [1,2]
C0332189
UMLS CUI [1,3]
C0020615
UMLS CUI [1,4]
C0205082
UMLS CUI [2,1]
C0332197
UMLS CUI [2,2]
C0235031
UMLS CUI [2,3]
C0332290
UMLS CUI [2,4]
C0342311
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
all participants
Description

Study Subject All

Type de données

boolean

Alias
UMLS CUI [1,1]
C0681850
UMLS CUI [1,2]
C0444868
have a hemoglobin level <12.0 grams/deciliter (g/dl) at screening
Description

Hemoglobin measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0518015
is currently a smoker or used tobacco products on a regular basis in the 6 months prior to screening, or intending to smoke during the study
Description

Tobacco use Regular

Type de données

boolean

Alias
UMLS CUI [1,1]
C0543414
UMLS CUI [1,2]
C0205272
healthy participants only
Description

Healthy Volunteers

Type de données

boolean

Alias
UMLS CUI [1]
C1708335
• regular use or intended use of over-the counter or prescription medication within 7 and 14 days, respectively, prior to dosing (apart from vitamin/mineral supplements or occasional use of acetaminophen or ibuprofen). if this situation arises, inclusion of an otherwise suitable participants may be at the discretion of the investigator
Description

Non-Prescription Drugs Regular | Prescription Drugs Regular | Exception Vitamin and Mineral Supplement | Exception Acetaminophen Infrequent | Exception Ibuprofen Infrequent

Type de données

boolean

Alias
UMLS CUI [1,1]
C0013231
UMLS CUI [1,2]
C0205272
UMLS CUI [2,1]
C0304227
UMLS CUI [2,2]
C0205272
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0724359
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0000970
UMLS CUI [4,3]
C0521114
UMLS CUI [5,1]
C1705847
UMLS CUI [5,2]
C0020740
UMLS CUI [5,3]
C0521114
participants with t1dm only
Description

Study Subject Insulin-Dependent Diabetes Mellitus

Type de données

boolean

Alias
UMLS CUI [1,1]
C0681850
UMLS CUI [1,2]
C0011854
regular use or intended use of any over-the-counter or prescription medications or nutritional supplements that affect blood glucose or the body's sensitivity to insulin or that promote weight loss within 14 days prior to dosing
Description

Non-Prescription Drugs Regular | Prescription Drugs Regular | Dietary Supplements Regular | Pharmaceutical Preparations Affecting Blood Glucose | Pharmaceutical Preparations Affecting Insulin Sensitivity | Pharmaceutical Preparations Promoting Weight loss

Type de données

boolean

Alias
UMLS CUI [1,1]
C0013231
UMLS CUI [1,2]
C0205272
UMLS CUI [2,1]
C0304227
UMLS CUI [2,2]
C0205272
UMLS CUI [3,1]
C0242295
UMLS CUI [3,2]
C0205272
UMLS CUI [4,1]
C0013227
UMLS CUI [4,2]
C0392760
UMLS CUI [4,3]
C0005802
UMLS CUI [5,1]
C0013227
UMLS CUI [5,2]
C0392760
UMLS CUI [5,3]
C0920563
UMLS CUI [6,1]
C0013227
UMLS CUI [6,2]
C0033414
UMLS CUI [6,3]
C1262477
are receiving chronic (lasting longer than 14 consecutive days) systemic or inhaled glucocorticoid therapy (excluding topical, intra-articular, and intraocular preparations) or have received such therapy within the 4 weeks before dosing
Description

Systemic Glucocorticoids chronic | Glucocorticoid therapy by Inhalation chronic | Exception Preparations Topical | Exception Preparations Intraarticular | Exception Preparations Intraocular

Type de données

boolean

Alias
UMLS CUI [1,1]
C3540777
UMLS CUI [1,2]
C0205191
UMLS CUI [2,1]
C0744425
UMLS CUI [2,2]
C0205535
UMLS CUI [2,3]
C0205191
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0013227
UMLS CUI [3,3]
C1522168
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0013227
UMLS CUI [4,3]
C1522204
UMLS CUI [5,1]
C1705847
UMLS CUI [5,2]
C0013227
UMLS CUI [5,3]
C1522223
require a total daily insulin dose exceeding 100 units (u)
Description

Insulin Cumulative Dose U/day

Type de données

boolean

Alias
UMLS CUI [1,1]
C0021641
UMLS CUI [1,2]
C2986497
UMLS CUI [1,3]
C0456683
have fasting triglycerides >400 mg/dl
Description

Serum fasting triglyceride measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0582824
Retour au début de la page

Similar models

Eligibility Healthy Volunteers NCT01654380

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Study Subject All
Item
all participants
boolean
C0681850 (UMLS CUI [1,1])
C0444868 (UMLS CUI [1,2])
Gender Healthy | Diabetes Mellitus, Insulin-Dependent
Item
are healthy males or participants with t1dm
boolean
C0079399 (UMLS CUI [1,1])
C3898900 (UMLS CUI [1,2])
C0011854 (UMLS CUI [2])
Body mass index
Item
have a screening body mass index (bmi) of 20.0-29.9 kilograms per square meter (kg/m^2)
boolean
C1305855 (UMLS CUI [1])
Healthy Volunteers
Item
healthy participants only
boolean
C1708335 (UMLS CUI [1])
Healthy Volunteers Medical History | Healthy Volunteers Physical Examination
Item
are overtly healthy, as determined by medical history and physical examination
boolean
C1708335 (UMLS CUI [1,1])
C0262926 (UMLS CUI [1,2])
C1708335 (UMLS CUI [2,1])
C0031809 (UMLS CUI [2,2])
Fasting blood glucose measurement
Item
have a fasting blood glucose <108 milligrams/deciliter (mg/dl) (6.0 millimoles/liter [mmol/l]) at screening
boolean
C0428568 (UMLS CUI [1])
Study Subject Insulin-Dependent Diabetes Mellitus
Item
participants with t1dm only
boolean
C0681850 (UMLS CUI [1,1])
C0011854 (UMLS CUI [1,2])
Insulin-Dependent Diabetes Mellitus Disease length
Item
have a diagnosis of t1dm for at least 1 year based on medical history
boolean
C0011854 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
C-peptide measurement
Item
have a screening c-peptide <0.5 nanogram/milliliter (ng/ml)
boolean
C0202100 (UMLS CUI [1])
Hemoglobin A1c measurement
Item
have a hemoglobin a1c (hba1c) of 6.0 to 9.0% at screening
boolean
C0474680 (UMLS CUI [1])
Absence Episode of Hypoglycemia Severe | Absence Neurologic Symptoms Consistent with Neuroglycopenia
Item
have had no episodes of severe hypoglycemia in the past 6 months (severe hypoglycemia is defined as having neurological symptoms consistent with neuroglycopenia and having required assistance in treatment by a second party)
boolean
C0332197 (UMLS CUI [1,1])
C0332189 (UMLS CUI [1,2])
C0020615 (UMLS CUI [1,3])
C0205082 (UMLS CUI [1,4])
C0332197 (UMLS CUI [2,1])
C0235031 (UMLS CUI [2,2])
C0332290 (UMLS CUI [2,3])
C0342311 (UMLS CUI [2,4])
Item Group
C0680251 (UMLS CUI)
Study Subject All
Item
all participants
boolean
C0681850 (UMLS CUI [1,1])
C0444868 (UMLS CUI [1,2])
Hemoglobin measurement
Item
have a hemoglobin level <12.0 grams/deciliter (g/dl) at screening
boolean
C0518015 (UMLS CUI [1])
Tobacco use Regular
Item
is currently a smoker or used tobacco products on a regular basis in the 6 months prior to screening, or intending to smoke during the study
boolean
C0543414 (UMLS CUI [1,1])
C0205272 (UMLS CUI [1,2])
Healthy Volunteers
Item
healthy participants only
boolean
C1708335 (UMLS CUI [1])
Non-Prescription Drugs Regular | Prescription Drugs Regular | Exception Vitamin and Mineral Supplement | Exception Acetaminophen Infrequent | Exception Ibuprofen Infrequent
Item
• regular use or intended use of over-the counter or prescription medication within 7 and 14 days, respectively, prior to dosing (apart from vitamin/mineral supplements or occasional use of acetaminophen or ibuprofen). if this situation arises, inclusion of an otherwise suitable participants may be at the discretion of the investigator
boolean
C0013231 (UMLS CUI [1,1])
C0205272 (UMLS CUI [1,2])
C0304227 (UMLS CUI [2,1])
C0205272 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0724359 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C0000970 (UMLS CUI [4,2])
C0521114 (UMLS CUI [4,3])
C1705847 (UMLS CUI [5,1])
C0020740 (UMLS CUI [5,2])
C0521114 (UMLS CUI [5,3])
Study Subject Insulin-Dependent Diabetes Mellitus
Item
participants with t1dm only
boolean
C0681850 (UMLS CUI [1,1])
C0011854 (UMLS CUI [1,2])
Non-Prescription Drugs Regular | Prescription Drugs Regular | Dietary Supplements Regular | Pharmaceutical Preparations Affecting Blood Glucose | Pharmaceutical Preparations Affecting Insulin Sensitivity | Pharmaceutical Preparations Promoting Weight loss
Item
regular use or intended use of any over-the-counter or prescription medications or nutritional supplements that affect blood glucose or the body's sensitivity to insulin or that promote weight loss within 14 days prior to dosing
boolean
C0013231 (UMLS CUI [1,1])
C0205272 (UMLS CUI [1,2])
C0304227 (UMLS CUI [2,1])
C0205272 (UMLS CUI [2,2])
C0242295 (UMLS CUI [3,1])
C0205272 (UMLS CUI [3,2])
C0013227 (UMLS CUI [4,1])
C0392760 (UMLS CUI [4,2])
C0005802 (UMLS CUI [4,3])
C0013227 (UMLS CUI [5,1])
C0392760 (UMLS CUI [5,2])
C0920563 (UMLS CUI [5,3])
C0013227 (UMLS CUI [6,1])
C0033414 (UMLS CUI [6,2])
C1262477 (UMLS CUI [6,3])
Systemic Glucocorticoids chronic | Glucocorticoid therapy by Inhalation chronic | Exception Preparations Topical | Exception Preparations Intraarticular | Exception Preparations Intraocular
Item
are receiving chronic (lasting longer than 14 consecutive days) systemic or inhaled glucocorticoid therapy (excluding topical, intra-articular, and intraocular preparations) or have received such therapy within the 4 weeks before dosing
boolean
C3540777 (UMLS CUI [1,1])
C0205191 (UMLS CUI [1,2])
C0744425 (UMLS CUI [2,1])
C0205535 (UMLS CUI [2,2])
C0205191 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0013227 (UMLS CUI [3,2])
C1522168 (UMLS CUI [3,3])
C1705847 (UMLS CUI [4,1])
C0013227 (UMLS CUI [4,2])
C1522204 (UMLS CUI [4,3])
C1705847 (UMLS CUI [5,1])
C0013227 (UMLS CUI [5,2])
C1522223 (UMLS CUI [5,3])
Insulin Cumulative Dose U/day
Item
require a total daily insulin dose exceeding 100 units (u)
boolean
C0021641 (UMLS CUI [1,1])
C2986497 (UMLS CUI [1,2])
C0456683 (UMLS CUI [1,3])
Serum fasting triglyceride measurement
Item
have fasting triglycerides >400 mg/dl
boolean
C0582824 (UMLS CUI [1])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial